Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D02YCH
|
|||
Former ID |
DIB005309
|
|||
Drug Name |
Icodextrin
|
|||
Synonyms |
Extraneal
Click to Show/Hide
|
|||
Drug Type |
Small molecular drug
|
|||
Indication | Kidney disease [ICD-11: GC2Z] | Approved | [1], [2] | |
Company |
Innovata plc
|
|||
Structure |
Download2D MOL |
|||
Formula |
C8H8Cl2N4
|
|||
Canonical SMILES |
C1=CC(=C(C(=C1)Cl)C=NN=C(N)N)Cl
|
|||
InChI |
1S/C8H8Cl2N4/c9-6-2-1-3-7(10)5(6)4-13-14-8(11)12/h1-4H,(H4,11,12,14)
|
|||
InChIKey |
WDZVGELJXXEGPV-UHFFFAOYSA-N
|
|||
CAS Number |
CAS 5051-62-7
|
|||
PubChem Compound ID | ||||
ADReCS Drug ID | BADD_D01124 |
References | Top | |||
---|---|---|---|---|
REF 1 | Drugs@FDA. U.S. Food and Drug Administration. U.S. Department of Health & Human Services. 2015 | |||
REF 2 | ClinicalTrials.gov (NCT00397358) Effect of Extraneal (Icodextrin)on Triglyceride Levels in PD Patients. U.S. National Institutes of Health. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.